MANUEL
PRAGA TERENTE
Profesor emérito
Columbia University Medical Center
Nueva York, Estados UnidosPublicacións en colaboración con investigadores/as de Columbia University Medical Center (11)
2023
-
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
Nature Medicine, Vol. 29, Núm. 7, pp. 1867-1876
-
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD
Journal of the American Society of Nephrology : JASN, Vol. 34, Núm. 6, pp. 955-968
-
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
The Lancet, Vol. 402, Núm. 10417, pp. 2077-2090
-
Glomerular diseases in pregnancy: pragmatic recommendations for clinical management
Kidney International, Vol. 103, Núm. 2, pp. 264-281
-
Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification
Mayo Clinic Proceedings
-
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification
Kidney International, Vol. 104, Núm. 6, pp. 1092-1102
2022
-
Diagnosis and Treatment of Patients With Focal Segmental Glomerulosclerosis/Steroid-Resistant Nephrotic Syndrome: A Delphi Survey
Kidney International Reports, Vol. 7, Núm. 9, pp. 2081-2085
2021
-
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis
American Journal of Kidney Diseases, Vol. 78, Núm. 3, pp. 340-349.e1
2017
-
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis
Kidney International Reports, Vol. 2, Núm. 5, pp. 800-810
2016
-
Obesity-related glomerulopathy: Clinical and pathologic characteristics and pathogenesis
Nature Reviews Nephrology, Vol. 12, Núm. 8, pp. 453-471
2014
-
Fatty kidney: Emerging role of ectopic lipid in obesity-related renal disease
The Lancet Diabetes and Endocrinology, Vol. 2, Núm. 5, pp. 417-426